Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery GP2

Path Created with Sketch.
Go to GP2 Normal Tissue GalleryGo back to Product Page
Adrenal gland - GP-2 negative pheochromocytoma.
Adrenal gland – GP-2 negative pheochromocytoma.
Breast - GP-2 negative invasive breast cancer of no special type (NST).
Breast – GP-2 negative invasive breast cancer of no special type (NST).
Colon - GP-2 negative colorectal adenocarcinoma.
Colon – GP-2 negative colorectal adenocarcinoma.
Esophagus - GP-2 negative adenocarcinoma.
Esophagus – GP-2 negative adenocarcinoma.
Kidney - GP-2 negative clear cell renal cell carcinoma.
Kidney – GP-2 negative clear cell renal cell carcinoma.
Larynx - GP-2 negative squamous cell carcinoma.
Larynx – GP-2 negative squamous cell carcinoma.
Larynx - Squamous cell carcinoma completely lacking GP-2 staining.
Larynx – Squamous cell carcinoma completely lacking GP-2 staining.
Liver - GP-2 negative cholangiocellular carcinoma.
Liver – GP-2 negative cholangiocellular carcinoma.
Lung - GP-2 negative adenocarcinoma.
Lung – GP-2 negative adenocarcinoma.
Ovary - GP-2 negative serous high-grade carcinoma
Ovary – GP-2 negative serous high-grade carcinoma
Pancreas - Acinar cell carcinoma showing strong GP-2 immunostaining of all tumor cells.
Pancreas – Acinar cell carcinoma showing strong GP-2 immunostaining of all tumor cells.
Pancreas - Acinar cell carcinoma with moderate to strong GP-2 immunostaining of >50% of tumor cells
Pancreas – Acinar cell carcinoma with moderate to strong GP-2 immunostaining of >50% of tumor cells
Pancreas - Acinar cell carcinoma with variable (weak to strong) GP-2 positivity of tumor cells.
Pancreas – Acinar cell carcinoma with variable (weak to strong) GP-2 positivity of tumor cells.
Pancreas - GP-2 negative ductal adenocarcinoma.
Pancreas – GP-2 negative ductal adenocarcinoma.
Pancreas - GP-2 negative neuroendocrine tumor.
Pancreas – GP-2 negative neuroendocrine tumor.
Penis - GP-2 negative squamous cell carcinoma.
Penis – GP-2 negative squamous cell carcinoma.
Prostate - GP-2 negative adenocarcinoma (Gleason 3+3=6)
Prostate – GP-2 negative adenocarcinoma (Gleason 3+3=6)
Soft tissue - GP-2 negative liposarcoma.
Soft tissue – GP-2 negative liposarcoma.
Stomach - Gastric adenocarcinoma showing focal weak to moderate GP-2 immunostaining.
Stomach – Gastric adenocarcinoma showing focal weak to moderate GP-2 immunostaining.
Stomach - GP-2 negative gastrointestinal stromal tumor (GIST).
Stomach – GP-2 negative gastrointestinal stromal tumor (GIST).
Testis - GP-2 negative seminoma.
Testis – GP-2 negative seminoma.
Thyroid - GP-2 negative medullary cancer.
Thyroid – GP-2 negative medullary cancer.
Thyroid - GP-2 negative papillary cancer.
Thyroid – GP-2 negative papillary cancer.
Urinary bladder - GP-2 negative muscle-invasive urothelial carcinoma.
Urinary bladder – GP-2 negative muscle-invasive urothelial carcinoma.
Uterus - GP-2 negative endometrium carcinoma.
Uterus – GP-2 negative endometrium carcinoma.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors